CAS NO: 943516-54-9Pondus hypotheticum: 111.18Formulae hypotheticae: C7H13NCurrent content: 98% HPLCProduct status: annonamDescriptio: 6, 6-dimethyl-3-azabicyclicus [3.1.0] hexane est compositio organica heterocyclica quae uti intermedium pharmaceuticum adhiberi potest.
CAS NO: 27511-79-1Pondus hypotheticum: 350.31Formulae hypotheticae: C8H14N8O6Svena content: XCVIII% HPLCProduct status: annonamDescription: Allopurinolum medium
CAS NO: 399017-10-8Pondus hypotheticum: 299.77Formulae hypotheticae: c13H14CINO3SCurrent content: 98% HPLCProduct status: annonamDescription: 2-(4-hydroxyphenyl) -4-methylthiazole-5-ethyl formatum hydrochloridum
CAS NO: 1193-21-1Pondus hypotheticum: 148.98Formulae hypotheticae: C4H2Cl2N2Current content: 98% HPLCProduct status: annonaeDescription: Inter bactericidi pyrimidin usus est ad productionem sulfamethoxil.
CAS NO: 24424-99-5Pondus hypotheticum: 218.25Formulae hypotheticae: C10H1805vena content: XCVIII% HPLCProduct status: annonamDescriptio: Di-tert-butyl dicarbonate (Boc anhydride) in synthesi organica adhibetur ad genesis tutelae tert-butoxycarbonyl introducendam, praesertim ad tutelam amino acidarum. Late usus est in medicina, interdum et peptide synthesis, cibus diam, cosmetics et alia synthesis producta.
CAS NO: 2386-60-9Pondus hypotheticum: 156.63Formulae hypotheticae: C4H9Clo2svena content: XCVIII% HPLCProduct status: annonamDescriptio: 1-butylsulfonyl chloridum
CAS NO: 334618-23-4Pondus hypotheticum: 261.66Formulae hypotheticae: C5H13CIN2Current content: 98% HPLCProduct status: annonamDescriptio: Usus heterocyclicus diamine n-arylation reactante in regente; synthesis reactants quae succedunt quinolones periculum phototoxicitatis reducere possunt.
CAS NO: 1428243-25-7Pondus hypotheticum: 277.31566Formulae hypotheticae: C15H19NO4current content: 98% HPLCProduct status: annonaeDescriptio: medium upatinib
CAS NO: 1094-61-7Pondus hypotheticum: 334.22Formulae hypotheticae: C11H15N2O8Pvena content: XCVIII% HPLCProduct status: annonamDescriptio: In mammalibus, β-nicotinamide mononucleotides a Nicotinamide (Nam) catalyzatae a Nampt, protease in vivo generantur, sequitur NAD+ catalyzum a nicotinamide mononucleotide chemical book adenosinum transferase. Nicotinamide mononucleotide directa via est ad supplendam NAD+.
CAS NO: 1124-11-4Pondus hypotheticum: 136,19Formulae hypotheticae: C8H12N2Current content: 98% HPLCProduct status: annonamDescriptio: 1) Maxime adhibetur ad parandum carnes et Cocos, peanuts, nuces, capulus, scelestum et alios sapores.2) Ponitur ut saporis agentis, suavitatis amplificator potionum alcoholicarum, sapor determinatio ac supplementum sigarellarum.III) pro medicamento productionem
CAS NO: 61718-80-7Pondus hypotheticum: 260.25Formulae hypotheticae: C13H15F302vena content: XCVIII% HPLCProduct status: annonamDescription: Fluvoxamine medium
CAS NO: 63-75-2Pondus hypotheticum: 155.19Formulae hypotheticae: C8H13NO2Current content: HPLC99%Product status: annonamDescription: electronic cigarette